161 related articles for article (PubMed ID: 2105712)
1. Retinal toxicity of recombinant tissue plasminogen activator in the rabbit.
Johnson MW; Olsen KR; Hernandez E; Irvine WD; Johnson RN
Arch Ophthalmol; 1990 Feb; 108(2):259-63. PubMed ID: 2105712
[TBL] [Abstract][Full Text] [Related]
2. Retinal toxicity of human tissue plasminogen activator in vitrectomized rabbit eyes.
Irvine WD; Johnson MW; Hernandez E; Olsen KR
Arch Ophthalmol; 1991 May; 109(5):718-22. PubMed ID: 1902663
[TBL] [Abstract][Full Text] [Related]
3. Retinal toxicity of commercial intravitreal tissue plasminogen activator solution in cat eyes.
Hrach CJ; Johnson MW; Hassan AS; Lei B; Sieving PA; Elner VM
Arch Ophthalmol; 2000 May; 118(5):659-63. PubMed ID: 10815158
[TBL] [Abstract][Full Text] [Related]
4. Retinal toxicity of intravitreal tenecteplase in the rabbit.
Rowley SA; Vijayasekaran S; Yu PK; McAllister IL; Yu DY
Br J Ophthalmol; 2004 Apr; 88(4):573-8. PubMed ID: 15031179
[TBL] [Abstract][Full Text] [Related]
5. A study of the ability of tissue plasminogen activator to diffuse into the subretinal space after intravitreal injection in rabbits.
Kamei M; Misono K; Lewis H
Am J Ophthalmol; 1999 Dec; 128(6):739-46. PubMed ID: 10612511
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of a commercial recombinant tissue-type plasminogen activator preparation in the subretinal space of the cat.
Benner JD; Morse LS; Toth CA; Landers MB; Hjelmeland LM
Arch Ophthalmol; 1991 Dec; 109(12):1731-6. PubMed ID: 1841586
[TBL] [Abstract][Full Text] [Related]
7. Tissue plasminogen activator treatment of experimental subretinal hemorrhage.
Lewis H; Resnick SC; Flannery JG; Straatsma BR
Am J Ophthalmol; 1991 Feb; 111(2):197-204. PubMed ID: 1899537
[TBL] [Abstract][Full Text] [Related]
8. Ocular toxicity of intravitreal tacrolimus.
Passos E; Genaidy MM; Peyman GA
Ophthalmic Surg Lasers; 2002; 33(2):140-4. PubMed ID: 11942546
[TBL] [Abstract][Full Text] [Related]
9. The effect of tissue plasminogen activator on retinal bleeding.
Sternberg P; Aguilar HE; Drews C; Aaberg TM
Arch Ophthalmol; 1990 May; 108(5):720-2. PubMed ID: 2110447
[TBL] [Abstract][Full Text] [Related]
10. The efficacy of plasminogen-urokinase combination in inducing posterior vitreous detachment.
Unal M; Peyman GA
Retina; 2000; 20(1):69-75. PubMed ID: 10696751
[TBL] [Abstract][Full Text] [Related]
11. The use of intravitreal tissue plasminogen activator in the treatment of experimental subretinal hemorrhage in the pig model.
Boone DE; Boldt HC; Ross RD; Folk JC; Kimura AE
Retina; 1996; 16(6):518-24. PubMed ID: 9002136
[TBL] [Abstract][Full Text] [Related]
12. Resolution of experimental intravitreal fibrin by tissue plasminogen activator.
Min WK; Kim YB
Korean J Ophthalmol; 1990 Dec; 4(2):58-65. PubMed ID: 2128708
[TBL] [Abstract][Full Text] [Related]
13. Tissue plasminogen activator treatment of experimental subretinal hemorrhage.
Johnson MW; Olsen KR; Hernandez E
Retina; 1991; 11(2):250-8. PubMed ID: 1925092
[TBL] [Abstract][Full Text] [Related]
14. Intravitreal injection of dispase causes retinal hemorrhages in rabbit and human eyes.
Jorge R; Oyamaguchi EK; Cardillo JA; Gobbi A; Laicine EM; Haddad A
Curr Eye Res; 2003 Feb; 26(2):107-12. PubMed ID: 12815529
[TBL] [Abstract][Full Text] [Related]
15. Investigation of the safety of tenecteplase to the outer retina.
McAllister IL; Vijayasekaran S; Khong CH; Yu DY
Clin Exp Ophthalmol; 2006 Nov; 34(8):787-93. PubMed ID: 17073903
[TBL] [Abstract][Full Text] [Related]
16. Toxicity of 1-(beta-D-arabinofuranosyl)cytosine after intravitreal injection in the rabbit eye.
Diets-Ouwehand JJ; de Keizer RJ; Vrensen GF; Groen-Jansen S; van Best JA
Graefes Arch Clin Exp Ophthalmol; 1992; 230(5):488-95. PubMed ID: 1521818
[TBL] [Abstract][Full Text] [Related]
17. Effect of intravitreal tissue plasminogen activator on experimental subretinal hemorrhage.
Coll GE; Sparrow JR; Marinovic A; Chang S
Retina; 1995; 15(4):319-26. PubMed ID: 8545578
[TBL] [Abstract][Full Text] [Related]
18. Increased retinal toxicity of intravitreal tissue plasminogen activator in a central retinal vein occlusion model.
Yamamoto T; Kamei M; Kunavisarut P; Suzuki M; Tano Y
Graefes Arch Clin Exp Ophthalmol; 2008 Apr; 246(4):509-14. PubMed ID: 17960414
[TBL] [Abstract][Full Text] [Related]
19. Intravitreal trifluorothymidine and retinal toxicity.
Pang MP; Peyman GA; Nikoleit J; Fiscella R; Kao G
Retina; 1986; 6(4):260-3. PubMed ID: 3107097
[TBL] [Abstract][Full Text] [Related]
20. Treatment of experimental vitreous hemorrhage with tissue plasminogen activator.
Min WK; Kim YB; Lee KM
Korean J Ophthalmol; 1990 Jun; 4(1):12-5. PubMed ID: 2120486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
